PortalPublikationenDesired Qualities of Endovascular Tools and Barriers to Trea...

Desired Qualities of Endovascular Tools and Barriers to Treating Medium Vessel Occlusion MeVO

Standard

Desired Qualities of Endovascular Tools and Barriers to Treating Medium Vessel Occlusion MeVO : Insights from the MeVO-FRONTIERS International Survey. / Kashani, Nima; Cimflova, Petra; Ospel, Johanna M; Kappelhof, Manon; Singh, Nishita; McDonough, Rosalie V; Almekhlafi, Mohammed A; Chen, Michael; Sakai, Nobuyuki; Fiehler, Jens; Ahmed, Uzair; Peeling, Lissa; Kelly, Michael; Goyal, Mayank.

in: CLIN NEURORADIOL, Jahrgang 33, Nr. 1, 03.2023, S. 155-160.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Kashani, N, Cimflova, P, Ospel, JM, Kappelhof, M, Singh, N, McDonough, RV, Almekhlafi, MA, Chen, M, Sakai, N, Fiehler, J, Ahmed, U, Peeling, L, Kelly, M & Goyal, M 2023, 'Desired Qualities of Endovascular Tools and Barriers to Treating Medium Vessel Occlusion MeVO: Insights from the MeVO-FRONTIERS International Survey', CLIN NEURORADIOL, Jg. 33, Nr. 1, S. 155-160. https://doi.org/10.1007/s00062-022-01196-5

APA

Kashani, N., Cimflova, P., Ospel, J. M., Kappelhof, M., Singh, N., McDonough, R. V., Almekhlafi, M. A., Chen, M., Sakai, N., Fiehler, J., Ahmed, U., Peeling, L., Kelly, M., & Goyal, M. (2023). Desired Qualities of Endovascular Tools and Barriers to Treating Medium Vessel Occlusion MeVO: Insights from the MeVO-FRONTIERS International Survey. CLIN NEURORADIOL, 33(1), 155-160. https://doi.org/10.1007/s00062-022-01196-5

Vancouver

Kashani N, Cimflova P, Ospel JM, Kappelhof M, Singh N, McDonough RV et al. Desired Qualities of Endovascular Tools and Barriers to Treating Medium Vessel Occlusion MeVO: Insights from the MeVO-FRONTIERS International Survey. CLIN NEURORADIOL. 2023 Mär;33(1):155-160. https://doi.org/10.1007/s00062-022-01196-5

Bibtex

@article{32743d77ef3d434fa6bd8a21a8aef1e9,
title = "Desired Qualities of Endovascular Tools and Barriers to Treating Medium Vessel Occlusion MeVO: Insights from the MeVO-FRONTIERS International Survey",
abstract = "BACKGROUND: Endovascular treatment (EVT) for stroke due to medium vessel occlusion (MeVO) can be technically challenging and specific endovascular tools are needed to safely and effectively recanalize these relatively small and fragile vessels. We aimed to gain insight into availability and desired qualities of endovascular devices used in MeVO stroke and examined barriers to adoption of MeVO EVT in clinical practice on a global scale.METHODS: We conducted a case-based international survey among neurointerventionalists. As a part of the survey, participants were asked whether they felt appropriate endovascular tools for MeVO stroke exist and are available to them in their clinical practice. We then examined barriers to adopting MeVO EVT and analyzed them by geographic regions.RESULTS: A total of 263 neurointerventionists participated, of which 178 (67.7%) and 83 (31.6%) provided responses on desired qualities of MeVO EVT tools and on barriers to their adoption in local practice, respectively. The majority 121/178 (68%) felt there was substantial room for improvement regarding existing tools. A large proportion 131/178 (73.6%) felt they had appropriate access to existing tools. The most commonly mentioned barrier for adopting MeVO EVT in North America was {"}awaiting better tools{"} (9/28 responses, 32.1%), while {"}awaiting better evidence{"} (8/26 responses, 30.8%), and the need for improved {"}funding{"} (7/26 responses, 26.9%) were important barriers in Europe.CONCLUSION: The majority of surveyed neurointerventionalists felt that dedicated MeVO EVT tools can be substantially improved upon. Different regions face various challenges in adoption of MeVO EVT, but overall, physicians are mostly awaiting better MeVO EVT tools.",
author = "Nima Kashani and Petra Cimflova and Ospel, {Johanna M} and Manon Kappelhof and Nishita Singh and McDonough, {Rosalie V} and Almekhlafi, {Mohammed A} and Michael Chen and Nobuyuki Sakai and Jens Fiehler and Uzair Ahmed and Lissa Peeling and Michael Kelly and Mayank Goyal",
note = "{\textcopyright} 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.",
year = "2023",
month = mar,
doi = "10.1007/s00062-022-01196-5",
language = "English",
volume = "33",
pages = "155--160",
journal = "CLIN NEURORADIOL",
issn = "1869-1439",
publisher = "Springer Heidelberg",
number = "1",

}

RIS

TY - JOUR

T1 - Desired Qualities of Endovascular Tools and Barriers to Treating Medium Vessel Occlusion MeVO

T2 - Insights from the MeVO-FRONTIERS International Survey

AU - Kashani, Nima

AU - Cimflova, Petra

AU - Ospel, Johanna M

AU - Kappelhof, Manon

AU - Singh, Nishita

AU - McDonough, Rosalie V

AU - Almekhlafi, Mohammed A

AU - Chen, Michael

AU - Sakai, Nobuyuki

AU - Fiehler, Jens

AU - Ahmed, Uzair

AU - Peeling, Lissa

AU - Kelly, Michael

AU - Goyal, Mayank

N1 - © 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.

PY - 2023/3

Y1 - 2023/3

N2 - BACKGROUND: Endovascular treatment (EVT) for stroke due to medium vessel occlusion (MeVO) can be technically challenging and specific endovascular tools are needed to safely and effectively recanalize these relatively small and fragile vessels. We aimed to gain insight into availability and desired qualities of endovascular devices used in MeVO stroke and examined barriers to adoption of MeVO EVT in clinical practice on a global scale.METHODS: We conducted a case-based international survey among neurointerventionalists. As a part of the survey, participants were asked whether they felt appropriate endovascular tools for MeVO stroke exist and are available to them in their clinical practice. We then examined barriers to adopting MeVO EVT and analyzed them by geographic regions.RESULTS: A total of 263 neurointerventionists participated, of which 178 (67.7%) and 83 (31.6%) provided responses on desired qualities of MeVO EVT tools and on barriers to their adoption in local practice, respectively. The majority 121/178 (68%) felt there was substantial room for improvement regarding existing tools. A large proportion 131/178 (73.6%) felt they had appropriate access to existing tools. The most commonly mentioned barrier for adopting MeVO EVT in North America was "awaiting better tools" (9/28 responses, 32.1%), while "awaiting better evidence" (8/26 responses, 30.8%), and the need for improved "funding" (7/26 responses, 26.9%) were important barriers in Europe.CONCLUSION: The majority of surveyed neurointerventionalists felt that dedicated MeVO EVT tools can be substantially improved upon. Different regions face various challenges in adoption of MeVO EVT, but overall, physicians are mostly awaiting better MeVO EVT tools.

AB - BACKGROUND: Endovascular treatment (EVT) for stroke due to medium vessel occlusion (MeVO) can be technically challenging and specific endovascular tools are needed to safely and effectively recanalize these relatively small and fragile vessels. We aimed to gain insight into availability and desired qualities of endovascular devices used in MeVO stroke and examined barriers to adoption of MeVO EVT in clinical practice on a global scale.METHODS: We conducted a case-based international survey among neurointerventionalists. As a part of the survey, participants were asked whether they felt appropriate endovascular tools for MeVO stroke exist and are available to them in their clinical practice. We then examined barriers to adopting MeVO EVT and analyzed them by geographic regions.RESULTS: A total of 263 neurointerventionists participated, of which 178 (67.7%) and 83 (31.6%) provided responses on desired qualities of MeVO EVT tools and on barriers to their adoption in local practice, respectively. The majority 121/178 (68%) felt there was substantial room for improvement regarding existing tools. A large proportion 131/178 (73.6%) felt they had appropriate access to existing tools. The most commonly mentioned barrier for adopting MeVO EVT in North America was "awaiting better tools" (9/28 responses, 32.1%), while "awaiting better evidence" (8/26 responses, 30.8%), and the need for improved "funding" (7/26 responses, 26.9%) were important barriers in Europe.CONCLUSION: The majority of surveyed neurointerventionalists felt that dedicated MeVO EVT tools can be substantially improved upon. Different regions face various challenges in adoption of MeVO EVT, but overall, physicians are mostly awaiting better MeVO EVT tools.

U2 - 10.1007/s00062-022-01196-5

DO - 10.1007/s00062-022-01196-5

M3 - SCORING: Journal article

C2 - 35854101

VL - 33

SP - 155

EP - 160

JO - CLIN NEURORADIOL

JF - CLIN NEURORADIOL

SN - 1869-1439

IS - 1

ER -